Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

Compared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting as the ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

A Yale team of researchers led by noted Indian American oncologist Dr. Kiran Turaga has developed new national guidelines for ...

Exelixis' STELLAR-303 trial shows zanzalintinib plus Tecentriq improved survival in colorectal cancer, with no new safety ...

Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

EXEL jumps 7.4% as STELLAR-303 trial hits key survival goal in colorectal cancer, boosting hopes for an approval of ...

Appendix cancer, once rare, is now rising sharply among younger people. Firstpost brings out an expert’s views on the risk ...

Recent data show pesticide residues reach household dust and bathing linens, exposing residents to enduring health risks.

A new study using one of the world's largest cancer registries shows that patient outcomes can be significantly impacted ...